RetractedArticleBioengineered2022

WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.

Juanjuan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.